Close

Ratings by Roth Capital (Scott Henry)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/21/2022 Champions Oncology CSBR Maintain Buy
(N/A)
 
 
  Details
9/2/2022 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
8/24/2022 Assertio Therapeutics ASRT Maintain Buy
(N/A)
 
 
  Details
8/24/2022 Catalyst Pharmaceutical Partners CPRX Downgrade Neutral
(Buy)
14.91
(12.09)
-18.91% Details
8/10/2022 Journey Medical Corp. DERM Maintain Buy
(N/A)
 
 
  Details
8/5/2022 Sensus Healthcare SRTS Maintain Buy
(N/A)
 
 
  Details
8/5/2022 Myomo Inc. MYO Maintain Buy
(N/A)
 
 
  Details
8/1/2022 Champions Oncology CSBR Maintain Buy
(N/A)
 
 
  Details
7/20/2022 Medexus Pharmaceuticals Inc. MEDXF Maintain Buy
(N/A)
 
 
  Details
7/12/2022 Journey Medical Corp. DERM Maintain Buy
(N/A)
 
 
  Details
6/14/2022 Assure Holdings Corp. IONM New Coverage Buy
(N/A)
2.05
(0.56)
-72.68% Details
6/7/2022 INVO Bioscience Inc. INVO Maintain Neutral
(N/A)
 
 
  Details
5/20/2022 Vivos Therapeutics VVOS Maintain Buy
(N/A)
 
 
  Details
5/16/2022 Inmed Pharmaceuticals INM Upgrade Buy
(Neutral)
0.83
(5.11)
515.66% Details
5/13/2022 Myomo Inc. MYO Maintain Buy
(N/A)
 
 
  Details
5/10/2022 Delcath Systems DCTH Maintain Buy
(N/A)
 
 
  Details
5/6/2022 Sensus Healthcare SRTS Maintain Buy
(N/A)
 
 
  Details
4/13/2022 INVO Bioscience Inc. invo Downgrade Neutral
(Buy)
2.07
(1.07)
-48.31% Details
3/10/2022 Myomo Inc. MYO Maintain Buy
(N/A)
 
 
  Details
2/28/2022 Sensus Healthcare SRTS Maintain Buy
(N/A)
 
 
  Details
2/22/2022 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
12/16/2021 Journey Medical Corp. DERM New Coverage Buy
(N/A)
6.75
(2.75)
-59.26% Details
11/16/2021 Vivos Therapeutics VVOS Maintain Buy
(N/A)
 
 
  Details
11/9/2021 Assertio Therapeutics ASRT Maintain Buy
(N/A)
 
 
  Details
11/1/2021 RenovoRx Inc. RNXT New Coverage Buy
(N/A)
5.18
(1.90)
-63.32% Details
5/14/2021 Inmed Pharmaceuticals INM Maintain Buy
(N/A)
 
 
  Details
3/15/2021 Champions Oncology CSBR Maintain Buy
(N/A)
 
 
  Details
2/26/2021 Sensus Healthcare SRTS Maintain Buy
(N/A)
 
 
  Details
12/29/2020 INVO Bioscience Inc. INVO New Coverage Buy
(N/A)
3.07
(1.07)
-65.15% Details
12/4/2020 Bionano Genomics BNGO Downgrade Neutral
(Buy)
0.49
(1.80)
267.35% Details
11/11/2020 Myomo Inc. MYO Upgrade Buy
(Neutral)
4.74
(1.73)
-63.5% Details
8/4/2020 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
7/28/2020 Champions Oncology CSBR Maintain Buy
(N/A)
 
 
  Details
6/4/2020 Delcath Systems DCTH New Coverage Buy
(N/A)
7.78
(3.10)
-60.15% Details
3/30/2020 BioSig Technologies Inc. BSGM New Coverage
(N/A)
6.13
(0.68)
-88.91% Details
3/27/2020 Soliton SOLY New Coverage Buy
(N/A)
8.80
(22.58)
156.59% Details
3/16/2020 Myomo Inc. MYO Maintain Neutral
(N/A)
 
 
  Details
2/10/2020 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
1/29/2020 Ligand Pharma LGND Maintain Buy
(N/A)
 
 
  Details
12/31/2019 Zynerba Pharmaceuticals ZYNE New Coverage Buy
(N/A)
5.64
(0.82)
-85.46% Details
11/14/2019 Myomo Inc. MYO Downgrade Neutral
(Buy)
0.69
(1.73)
150.72% Details
10/11/2019 Intec Pharma Ltd. NTEC Downgrade Neutral
(Buy)
0.72
(9.63)
1237.5% Details
9/30/2019 Daxor Corp. DXR New Coverage Neutral
(N/A)
9.62
(13.00)
35.14% Details
9/25/2019 Fortress Biotech FBIO Maintain Buy
(N/A)
 
 
  Details
9/20/2019 Champions Oncology CSBR New Coverage Buy
(N/A)
6.08
(7.68)
26.32% Details
9/5/2019 Kempharm KMPH Downgrade Neutral
(Buy)
0.95
(5.68)
497.89% Details
5/9/2019 Catalyst Pharmaceutical Partners CPRX Maintain Buy
(N/A)
 
 
  Details
4/18/2019 Tonix Pharma TNXP Upgrade Buy
(Neutral)
2.43
(0.53)
-78.19% Details
4/3/2019 BioPharmX Corp BPMX Maintain Buy
(N/A)
 
 
  Details
3/25/2019 Recro Pharma REPH Downgrade Neutral
(Buy)
9.72
(2.09)
-78.5% Details
3/18/2019 Restoration Robotics HAIR Downgrade Neutral
(Buy)
0.90
(0.38)
-57.78% Details
12/31/2018 Dynatronics DYNT New Coverage Buy
(N/A)
2.86
(0.52)
-81.82% Details
12/17/2018 Catalyst Pharmaceutical Partners CPRX Maintain Buy
(N/A)
 
 
  Details
11/29/2018 Q BioMed QBIO Downgrade Neutral
(Buy)
1.90
(0.02)
-98.95% Details
11/7/2018 Recro Pharma REPH Maintain Buy
(N/A)
 
 
  Details
10/29/2018 Ligand Pharma LGND Upgrade Buy
(Neutral)
167.06
(77.13)
-53.83% Details
10/5/2018 Intec Pharma Ltd. NTEC New Coverage Buy
(N/A)
5.20
(0.72)
-86.15% Details
9/4/2018 Catalyst Pharmaceutical Partners CPRX Maintain Buy
(N/A)
 
 
  Details
8/20/2018 Lannett Co LCI Downgrade Neutral
(Buy)
13.50
(0.48)
-96.44% Details
8/16/2018 Ritter Pharmaceuticals RTTR Maintain Buy
(N/A)
 
 
  Details
8/16/2018 Restoration Robotics HAIR Maintain Buy
(N/A)
 
 
  Details
8/14/2018 BioDelivery Sciences International BDSI Maintain Buy
(N/A)
 
 
  Details